| The impact of microRNAs on protein output D Baek, J Villén, C Shin, FD Camargo, SP Gygi, DP Bartel Nature 455 (7209), 64-71, 2008 | 4420 | 2008 |
| Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 JB Johnnidis, MH Harris, RT Wheeler, S Stehling-Sun, MH Lam, O Kirak, ... Nature 451 (7182), 1125-1129, 2008 | 1427 | 2008 |
| YAP1 increases organ size and expands undifferentiated progenitor cells FD Camargo, S Gokhale, JB Johnnidis, D Fu, GW Bell, R Jaenisch, ... Current biology 17 (23), 2054-2060, 2007 | 1382 | 2007 |
| Yap1 acts downstream of α-catenin to control epidermal proliferation K Schlegelmilch, M Mohseni, O Kirak, J Pruszak, JR Rodriguez, D Zhou, ... Cell 144 (5), 782-795, 2011 | 1107 | 2011 |
| Clonal dynamics of native haematopoiesis J Sun, A Ramos, B Chapman, JB Johnnidis, L Le, YJ Ho, A Klein, ... Nature 514 (7522), 322-327, 2014 | 877 | 2014 |
| Hippo pathway activity influences liver cell fate D Yimlamai, C Christodoulou, GG Galli, K Yanger, B Pepe-Mooney, ... Cell 157 (6), 1324-1338, 2014 | 835 | 2014 |
| Muscle-derived hematopoietic stem cells are hematopoietic in origin SL McKinney-Freeman, KA Jackson, FD Camargo, G Ferrari, F Mavilio, ... Proceedings of the National Academy of Sciences 99 (3), 1341-1346, 2002 | 608 | 2002 |
| YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy A von Gise, Z Lin, K Schlegelmilch, LB Honor, GM Pan, JN Buck, Q Ma, ... Proceedings of the National Academy of Sciences 109 (7), 2394-2399, 2012 | 595 | 2012 |
| Restriction of intestinal stem cell expansion and the regenerative response by YAP ER Barry, T Morikawa, BL Butler, K Shrestha, R De La Rosa, KS Yan, ... Nature 493 (7430), 106-110, 2013 | 560 | 2013 |
| Clonal analysis of lineage fate in native haematopoiesis AE Rodriguez-Fraticelli, SL Wolock, CS Weinreb, R Panero, SH Patel, ... Nature 553 (7687), 212-216, 2018 | 542 | 2018 |
| Lineage tracing on transcriptional landscapes links state to fate during differentiation C Weinreb, A Rodriguez-Fraticelli, FD Camargo, AM Klein Science 367 (6479), eaaw3381, 2020 | 523 | 2020 |
| Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates FD Camargo, R Green, Y Capetenaki, KA Jackson, MA Goodell Nature medicine 9 (12), 1520-1527, 2003 | 508 | 2003 |
| Oct4 expression is not required for mouse somatic stem cell self-renewal CJ Lengner, FD Camargo, K Hochedlinger, GG Welstead, S Zaidi, ... Cell stem cell 1 (4), 403-415, 2007 | 505 | 2007 |
| YAP mediates crosstalk between the Hippo and PI (3) K–TOR pathways by suppressing PTEN via miR-29 K Tumaneng, K Schlegelmilch, RC Russell, D Yimlamai, H Basnet, ... Nature cell biology 14 (12), 1322-1329, 2012 | 496 | 2012 |
| Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance D Zhou, Y Zhang, H Wu, E Barry, Y Yin, E Lawrence, D Dawson, JE Willis, ... Proceedings of the National Academy of Sciences 108 (49), E1312-E1320, 2011 | 485 | 2011 |
| Cytokinesis failure triggers hippo tumor suppressor pathway activation NJ Ganem, H Cornils, SY Chiu, KP O’Rourke, J Arnaud, D Yimlamai, ... Cell 158 (4), 833-848, 2014 | 390 | 2014 |
| Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer M Mori, R Triboulet, M Mohseni, K Schlegelmilch, K Shrestha, ... Cell 156 (5), 893-906, 2014 | 384 | 2014 |
| α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1 MR Silvis, BT Kreger, WH Lien, O Klezovitch, GM Rudakova, FD Camargo, ... Science signaling 4 (174), ra33-ra33, 2011 | 380 | 2011 |
| Comprehensive molecular characterization of the hippo signaling pathway in cancer Y Wang, X Xu, D Maglic, MT Dill, K Mojumdar, PKS Ng, KJ Jeong, ... Cell reports 25 (5), 1304-1317. e5, 2018 | 373 | 2018 |
| Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners FD Camargo, M Finegold, MA Goodell The Journal of clinical investigation 113 (9), 1266-1270, 2004 | 344 | 2004 |
